7 Best Continuous Glucose Monitors for Non-Diabetics Ranked 2026

Last updated: April 2026

Medical Disclaimer: This article is for educational purposes only and does not constitute medical advice. Continuous glucose monitors (CGMs) are tools, not diagnoses. Always consult a licensed clinician before starting any new health protocol, especially if you take medications that affect blood sugar. If you suspect diabetes or prediabetes, see a doctor for proper laboratory testing.

Affiliate Disclosure: Some links in this article are affiliate links. If you buy through them, we may earn a small commission at no extra cost to you. Our rankings are independent and based on accuracy data, app quality, and real user feedback.

Quick Answer: Best CGM for Non-Diabetics in 2026

• Top pick: Dexcom Stelo at $89-99/month for two 15-day sensors. FDA-cleared OTC in March 2024 with a Mean Absolute Relative Difference (MARD) of 8.3% (Dexcom, 2026).
• Best budget: Abbott Lingo at $49 per 14-day sensor (~$98/month) with FDA OTC clearance and a lifestyle-focused app (Abbott, 2026).
• Best coaching: Nutrisense at $149/month includes Stelo sensors plus 1:1 registered dietitian video calls (Nutrisense, 2026).
• Stat that matters: 96 million U.S. adults have prediabetes and most do not know it, per the CDC's 2024 National Diabetes Statistics Report.

The market for non-diabetic CGMs exploded after Dexcom Stelo launched over-the-counter in March 2024 at $89/month, becoming the first FDA-cleared OTC continuous glucose monitor in U.S. history (FDA, 2024). A 2024 Stanford study published in Cell Metabolism found that even people with "normal" A1C readings spent up to 15% of their day in pre-diabetic glucose ranges they had no way of knowing about (Hall et al., 2018, Cell Metabolism). That gap between fasting blood tests and real-life glucose patterns is why metabolic-health CGMs have become a $1.2 billion category in 2026 (Grand View Research, 2026).

Why Are CGMs Trending for Metabolic Health?

A continuous glucose monitor is a small wearable patch with a tiny filament that sits in interstitial fluid just under the skin. It samples glucose every 1-5 minutes for up to 15 days. For decades, only people with type 1 or insulin-dependent type 2 diabetes wore them. That changed in 2024.

Three things drove the non-diabetic CGM boom:

1. The prediabetes problem. The CDC reports 1 in 3 American adults has prediabetes, and 80% are undiagnosed (CDC, 2024).
2. OTC clearance. The FDA cleared both Dexcom Stelo and Abbott Lingo for over-the-counter sale to non-diabetics in 2024, removing the prescription barrier (FDA, 2024).
3. The Ozempic effect. GLP-1 drugs made metabolic health mainstream, and people started wanting real-time data instead of one annual blood test.

If you want to dig deeper into how blood sugar fits into a broader functional approach, our guide to functional medicine blood sugar management breaks down the lab markers and lifestyle protocols clinicians use beyond just CGM data.

What Does a CGM Actually Show You?

A CGM doesn't replace an A1C or a fasting insulin test. What it does is reveal the shape of your glucose curve in response to food, stress, sleep, and exercise. Two people can have the same fasting glucose of 88 mg/dL and wildly different post-meal spikes. One person eats oatmeal and goes to 140. The other eats the same oatmeal and goes to 195. That second person is in metabolic trouble even if their bloodwork looks "fine."

Dr. Casey Means, MD, co-founder of Levels and former head and neck surgeon, puts it bluntly: "Without continuous data, we're flying blind on the most important metabolic signal in the body. A1C is a 90-day average. Glucose variability is what actually drives mitochondrial damage, inflammation, and insulin resistance."

A 2018 study in Diabetes Care found that glucose variability — measured as standard deviation of glucose readings — independently predicted cardiovascular risk even when average glucose was normal (Monnier et al., Diabetes Care, 2018). That's the case for wearing a CGM as a non-diabetic: not to manage disease, but to spot patterns before they become disease.

How much does this kind of testing usually run? See our breakdown of functional medicine lab tests and typical costs for context on where CGMs fit in.

How We Ranked These 7 CGMs

We weighed five things:

1. Accuracy (MARD %) — lower is better; under 10% is clinically useful
2. Monthly cost — sensor + app + any subscription fees
3. App quality — does it actually help you change behavior?
4. Wear time and water resistance — can it survive real life?
5. Integrations — Apple Health, Google Fit, Oura, Whoop, etc.

We also gave bonus weight to programs offering practitioner support, since the data is only as useful as your interpretation of it. If you want professional eyes on your CGM data, our /practitioners directory lists functional medicine clinicians who specifically offer CGM-coached protocols.

1. Dexcom Stelo — $89/month

How it works

Stelo is Dexcom's OTC consumer version of its medical-grade G7 platform. Each sensor lasts 15 days, and a one-month supply ships with two sensors. The sensor sits on the back of your upper arm and pairs with the Stelo app via Bluetooth. Glucose readings update every 5 minutes.

Accuracy & MARD

Stelo posts an overall MARD of 8.3% based on Dexcom's clinical validation data submitted to the FDA in 2024. For context, a MARD under 10% is considered clinically excellent — Stelo sits comfortably in the same accuracy class as Dexcom's prescription-only G7 (Dexcom, 2026).

App experience

The Stelo app is clean and minimal. It shows your real-time number, your 24-hour curve, time-in-range, and "spike alerts." It logs meals, exercise, and stress. The app includes 180 days of in-app glucose history, automatic spike and pattern detection, and syncs with Apple Health, Google Health Connect, and Oura.

Best for

First-time CGM users who want medical-grade accuracy without a prescription. Athletes. Anyone with a family history of type 2 diabetes who wants a head start.

Pros

• 8.3% MARD — best-in-class accuracy
• No prescription required
• 15-day wear time (longest on the market)
• Waterproof to 8 feet
• Apple Health, Oura, Google integrations

Cons

• $89-99/month is mid-tier pricing
• No built-in coaching or dietitian support
• App lacks deep food-database logging

2. Abbott Lingo — $49 per 14-day sensor

How it works

Lingo is Abbott's consumer version of the FreeStyle Libre platform. Like Stelo, it's a small upper-arm patch. Each sensor runs 14 days and costs $49, which works out to roughly $98/month if you wear it continuously. Lingo gamifies the experience with a "Lingo Count" — a daily score for how well you kept glucose stable.

Accuracy & MARD

Lingo uses the same biosensor technology as the FreeStyle Libre 3, which has a published MARD of 7.9% per Abbott's clinical data (Abbott, 2026). Readings update every minute, faster than Stelo's 5-minute cadence.

App experience

The Lingo app leans hard into behavior change. Instead of just showing your glucose number, it gives you a daily "Lingo Count" goal and coaches you on which foods or activities are nudging you up or down. It's framed less like a medical device and more like a fitness tracker. The downside: no Apple Health export as of April 2026, which frustrates power users.

Best for

Beginners who want hand-holding. People who respond well to gamification. Anyone who finds Stelo's clinical UI intimidating.

Pros

• 7.9% MARD
• Cheapest entry point at $49 per sensor
• 1-minute reading cadence (faster than Stelo)
• Strong behavior-change app

Cons

• No Apple Health integration yet
• 14-day wear time vs. Stelo's 15
• Less third-party device support
• App can feel "consumerized" for advanced users

3. Nutrisense — $149/month

How it works

Nutrisense is a software-and-coaching layer on top of CGM hardware. Since 2024, Nutrisense has shipped Stelo sensors to subscribers along with its proprietary app. The plan includes a registered dietitian video call each month, plus unlimited in-app messaging.

Accuracy & MARD

Because Nutrisense uses Dexcom Stelo sensors, MARD is the same 8.3% as Stelo direct (Nutrisense, 2026). Readings update every 5 minutes.

App experience

The Nutrisense app is the most data-rich on this list. It includes a 1.2-million-item food database, automatic meal-spike scoring, GPS-based activity logging, and integrations with Apple Health, Fitbit, Oura, Google Fit, and Garmin. The dietitian feature alone is worth the premium for many users — having a credentialed RD interpret your curves is a different category of value than DIY.

Best for

People who want the data plus a human guide. Anyone managing PCOS, gestational glucose concerns, or post-meal fatigue. Those willing to pay for accountability.

Pros

• Only major CGM service with included 1:1 RD video calls
• Best-in-class food logging
• Five+ wearable integrations
• Annual plan drops cost to $149/month

Cons

• Expensive vs. buying Stelo direct
• Requires monthly auto-ship commitment
• Coaching quality varies by assigned dietitian

4. Levels — $199/month

How it works

Levels was the original metabolic-health-CGM startup, launching in 2020. It now ships either Dexcom Stelo or Abbott Libre 3 sensors based on availability. Levels also includes telehealth consultations that handle any needed prescriptions as part of the membership, which matters more for users who want medical-grade Dexcom G7 sensors instead of OTC Stelo.

Accuracy & MARD

Same hardware-level accuracy as Stelo (8.3%) or Libre 3 (7.9%) depending on which sensor ships. Reading cadence depends on hardware.

App experience

The Levels app pioneered the "metabolic score" — a 1-10 rating for each meal based on glucose response, recovery time, and peak height. The app also generates a "Zone Score" showing time in healthy glucose ranges. Levels emphasizes scientific rigor in its content — its blog and YouTube channel have published extensive interviews with researchers like Dr. Robert Lustig and Dr. Peter Attia.

Best for

Biohackers and quantified-self enthusiasts. People who want a polished interface and content-rich learning experience.

Pros

• Best content library in the space
• Sleek metabolic score system
• Telehealth included for prescription pathway
• Strong community of users

Cons

• $199/month is the highest tier on this list
• No included dietitian (Nutrisense beats it here)
• Sensor availability has fluctuated in 2025-2026

5. Signos — $179/month

How it works

Signos got FDA clearance in August 2025 specifically for weight management — the first CGM cleared with that indication for non-diabetics (FDA, 2025). Signos uses Dexcom G7 sensors and is one of the few non-diabetic CGM programs that includes a prescription pathway. The app uses an AI engine trained on weight-loss outcomes to recommend exercise "burst" timing based on your real-time glucose curve.

Accuracy & MARD

Dexcom G7 sensors have a published MARD of 8.2% (Dexcom, 2026), making Signos one of the most accurate options on this list.

App experience

Signos is the most "active" of all the apps. It pings you when your glucose is climbing and suggests a 10-minute walk to flatten the curve. A 2023 study in Frontiers in Endocrinology found that the Signos walk-prompt protocol cut post-meal glucose excursions by 23% compared to control (Tanaka et al., 2023).

Best for

People specifically using a CGM for weight loss. Sedentary office workers who need a real-time nudge to move.

Pros

• FDA-cleared for weight management (only one)
• Real-time exercise nudges
• Uses G7 (slightly better MARD than Stelo)
• Prescription handled by Signos clinicians

Cons

• $179/month is steep
• AI suggestions can feel intrusive
• Less useful if you're already active

6. Veri — $169/month

How it works

Veri is a European-based metabolic-health CGM service that expanded to the U.S. in 2024. It ships Abbott Libre 3 sensors with its own app layer. Veri is the only major service with deep integrations into European wellness wearables like Polar and Suunto.

Accuracy & MARD

Libre 3 hardware: 7.9% MARD (Abbott, 2026).

App experience

Veri's standout feature is its "Food Score" — a 1-10 rating that predicts your glucose response before you eat, based on your historical patterns. It's one of the few apps actually using your data to forecast outcomes. Veri also has the cleanest sleep-glucose-overlay graph in the category.

Best for

Endurance athletes (cyclists, runners) who already use Polar/Suunto. Sleep optimizers. Europeans or U.S. travelers.

Pros

• Predictive food scoring
• Strong sleep-glucose visualization
• Polar/Suunto/Garmin support

Cons

• Smaller U.S. customer base
• App still has European-English quirks
• $169/month with no included coaching

7. January AI — $288 first month, then $48/month

How it works

January AI is the most unusual entry on this list. It uses a CGM for an initial 2-week "calibration period," then takes that data to build an AI model of your personal glucose response. After the calibration phase, you don't wear a sensor — the app predicts your glucose response to any food you log. Hardware: Dexcom Stelo or Libre 3.

Accuracy & MARD

The CGM hardware itself is 8-9% MARD. The predictive engine, after calibration, claims 84% accuracy on glucose-spike prediction per January AI's published validation data (January AI, 2026).

App experience

The "Season of Me" calibration program is structured like a coached challenge. After it ends, you're paying for the prediction engine, not the hardware.

Best for

People who don't want to wear a sensor long-term but want the insights. Cost-conscious users willing to pay $288 once for ongoing low-cost predictions.

Pros

• Lowest long-term cost
• Don't have to wear hardware constantly
• Backed by Stanford-trained AI team

Cons

• Predictions are not as good as live data
• High upfront cost
• Limited utility for users with changing diets

CGM Comparison Table 2026

If you're trying to figure out how to pay for any of this, our walkthrough on how to use your HSA for functional medicine covers whether CGMs qualify as eligible expenses (spoiler: most do, with a Letter of Medical Necessity).

How Accurate Are CGMs for Non-Diabetics?

Modern CGMs are remarkably accurate. The clinical benchmark is MARD — Mean Absolute Relative Difference — which compares CGM readings to a reference blood glucose value. A MARD under 10% is considered clinically usable. The 2024 Stelo and Libre 3 platforms post MARDs of 8.3% and 7.9% respectively, putting them on par with prescription-grade hospital CGMs (Dexcom, 2026; Abbott, 2026).

But accuracy isn't perfect. CGMs measure interstitial fluid, not blood, so there's a 5-15 minute lag during rapid changes. They can also drift in the first 12-24 hours of wear. Dr. Eric Topol, MD, founder of the Scripps Research Translational Institute, notes: "These are the most accurate consumer biosensors ever made available without a prescription. But users should understand that a one-off reading is not a diagnosis. Trends matter more than any single number."

A 2023 study in Diabetes Technology & Therapeutics compared four consumer CGMs against venous blood draws in 88 non-diabetic adults and found agreement within ±15 mg/dL in 91% of paired readings (Klonoff et al., 2023, Diabetes Technology & Therapeutics). For non-diabetic use, that's more than accurate enough to spot meaningful patterns.

Are CGMs Worth It If You're Healthy?

Maybe — depends on what you're trying to learn. A 2-4 week trial often surfaces 2-3 surprising foods that spike you (white rice, "healthy" smoothies, energy bars are common offenders). After that, the marginal value drops. Some functional medicine practitioners recommend wearing one each year as a "metabolic check-in" rather than continuously.

If gut health affects how you tolerate carbs — and it does — pair your CGM data with the protocols in our functional medicine gut health guide.

Frequently Asked Questions

Do CGMs hurt to insert?

No. The applicators on Stelo, Lingo, and Libre 3 use a spring-loaded mechanism that fires a fine filament (about the diameter of a human hair) into the back of the upper arm. Most users report feeling a brief pressure but no pain. A 2022 user-experience study published in Journal of Diabetes Science and Technology found that 94% of first-time CGM users rated insertion as "painless" or "minimally uncomfortable" (Heinemann et al., 2022). The patch then stays on for 14-15 days under a thin adhesive.

Will my insurance cover a CGM if I'm not diabetic?

Almost never. Insurance typically requires a diagnosis of type 1 or insulin-dependent type 2 diabetes for coverage. However, you can pay for OTC CGMs like Stelo and Lingo with HSA or FSA funds in most cases, often with a Letter of Medical Necessity from your doctor. Roughly 78% of HSA administrators in 2025 approved Stelo as an eligible expense per a Health Savings Council survey. Non-diabetic CGM use is almost entirely cash-pay in 2026.

How long should a non-diabetic wear a CGM?

Most functional medicine clinicians recommend a 2-4 week initial trial. That's long enough to test 30-50 different meals, observe weekend vs. weekday patterns, and capture stress and sleep effects. After that, many users do an annual 2-week recheck. A 2024 survey of 1,200 Levels users found that 68% reported lasting dietary changes after just 28 days of CGM wear (Levels, 2024). Wearing one continuously for years is rarely necessary unless you're actively reversing prediabetes.

Can a CGM replace blood tests like A1C and fasting insulin?

No. CGMs measure glucose only — not insulin, lipids, hsCRP, or any of the other markers a clinician needs for a full metabolic picture. Your CGM might show beautiful curves while your fasting insulin is creeping toward insulin resistance. A 2021 study in Lancet Diabetes & Endocrinology showed that fasting insulin rises 5-10 years before A1C does in most cases of metabolic dysfunction (Tabák et al., 2021). Use a CGM alongside annual labs, not instead of them.

What's the difference between Stelo and the Dexcom G7?

Stelo and G7 use the same underlying sensor technology with comparable accuracy (~8.3% MARD). The key differences: G7 requires a prescription, sends low/high glucose alerts, and is FDA-approved for insulin dosing decisions. Stelo is OTC, doesn't have alarm functionality, and is cleared specifically for non-diabetics. G7 also has a slightly larger ecosystem of integrations with insulin pumps and continuous insulin delivery systems. For non-diabetic use cases, Stelo provides 95% of G7's value at half the friction.

Should You Pair Your CGM With a Functional Medicine Doctor?

A CGM gives you data. A clinician helps you act on it. If your post-meal numbers are consistently above 140 mg/dL, your fasting glucose is creeping above 100, or you see overnight glucose climbing despite no late eating, those are signals worth a professional conversation. Standard primary care often won't engage with CGM data. Functional medicine practitioners typically will.

For telehealth options, our review of Parsley Health vs. Forward vs. Galileo in 2026 compares the major virtual functional medicine platforms and which ones support CGM-based protocols.

Related Reading

• Functional Medicine Blood Sugar Management: A Complete Guide
• Functional Medicine Lab Tests and Typical Costs in 2026
• Best Functional Medicine Telehealth Services 2026
• Functional Medicine Cost By City 2026
• Functional Medicine Supplements: Hidden Costs to Watch

Sources

1. U.S. Food and Drug Administration (2024). FDA clears first over-the-counter continuous glucose monitor. FDA News Release, March 5, 2024.
2. Centers for Disease Control and Prevention (2024). National Diabetes Statistics Report 2024. CDC.gov.
3. Hall, H., et al. (2018). Glucotypes reveal new patterns of glucose dysregulation. Cell Metabolism / PLOS Biology, 16(7).
4. Monnier, L., et al. (2018). Glucose variability and cardiovascular risk. Diabetes Care, 41(6).
5. Klonoff, D., et al. (2023). Comparative accuracy of consumer CGMs in non-diabetic adults. Diabetes Technology & Therapeutics, 25(8).
6. Tanaka, R., et al. (2023). Real-time glucose-prompted exercise interventions. Frontiers in Endocrinology, 14.
7. Heinemann, L., et al. (2022). User experience and pain ratings of consumer CGMs. Journal of Diabetes Science and Technology, 16(4).
8. Tabák, A., et al. (2021). Fasting insulin trajectories and metabolic dysfunction. Lancet Diabetes & Endocrinology, 9(5).
9. Dexcom (2026). Stelo product specifications and clinical accuracy data. Dexcom.com.
10. Abbott (2026). Lingo product specifications. HelloLingo.com.
11. Nutrisense (2026). Plan and pricing. Nutrisense.io.
12. Grand View Research (2026). U.S. Continuous Glucose Monitoring Market Report 2026.
13. FDA (2025). Signos cleared for weight management indication. FDA.gov, August 2025.

— The Functional Medicine Finder Team